Literature DB >> 17260193

No increased stem subsidence after arthroplasty in young patients with femoral head osteonecrosis: 41 patients followed for 1-9 years.

Akif Ince1, Johannes Lermann, Sascha Göbel, Nicole Wollmerstedt, Christian Hendrich.   

Abstract

BACKGROUND: Poor bone stock in patients with osteonecrosis of the femoral head may be a reason for poor outcome after hip replacement. One way of studying bone quality is to measure implant migration. We thus investigated the clinical and radiographic results of cementless THR in younger patients with femoral head osteonecrosis. PATIENTS AND METHODS: We studied hips in 41 patients (mean age 48 (25-63) years) with a cementless hip arthroplasty after late stage osteonecrosis. Clinical evaluation was by the Harris hip score, the WOMAC score and the SF-36 score. Stem subsidence was measured with the Ein Bild Roentgen Analyse femoral component analysis (EBRA-FCA) at 3, 12, 24, 60, and 72 months after operation. The average duration of follow-up was 7(1-9) years, with less than 2 years for 2 patients.
RESULTS: There was no revision of any hip. No radiographic or clinical stem loosening was seen. After 60 months, the cementless stems showed a median subsidence of -0.7 mm (95% CI: -0.9 to -0.2). No femoral osteolysis occurred. Femoral radiolucent lines, all < 1 mm, were seen in 10 hips. At the latest follow-up the Harris hip score was 83 (23-100) points.
INTERPRETATION: Our findings for porous-coated stems in patients with femoral osteonecrosis indicate no greater risk of stem subsidence and rate of osteolysis after an average of 7 years follow-up. Thus, we continue to use uncemented stems in younger patients with femoral osteonecrosis. However, continued follow-up will be necessary to evaluate the long-term outcome.

Entities:  

Mesh:

Year:  2006        PMID: 17260193     DOI: 10.1080/17453670610013141

Source DB:  PubMed          Journal:  Acta Orthop        ISSN: 1745-3674            Impact factor:   3.717


  7 in total

1.  Outcomes of total hip arthroplasty in patients with osteonecrosis of the femoral head-a current review.

Authors:  Todd P Pierce; Randa K Elmallah; Julio J Jauregui; Daniel F Verna; Michael A Mont
Journal:  Curr Rev Musculoskelet Med       Date:  2015-09

Review 2.  Osteonecrosis is not a predictor of poor outcomes in primary total hip arthroplasty: a systematic literature review.

Authors:  Henning R Johannson; Michael G Zywiel; David R Marker; Lynne C Jones; Mike S McGrath; Michael A Mont
Journal:  Int Orthop       Date:  2010-02-25       Impact factor: 3.075

3.  High incidence of migration with poor initial fixation of the Accolade stem.

Authors:  Craig A White; Sasha Carsen; Kevin Rasuli; Robert J Feibel; Paul R Kim; Paul E Beaulé
Journal:  Clin Orthop Relat Res       Date:  2012-02       Impact factor: 4.176

4.  Radiographic Subsidence in Asymptomatic Patients After THR Using the Furlong Active HAP Stem.

Authors:  José Cordero-Ampuero; Pablo Peñalver; Rodrigo Antón; María Galán; Enrique Cordero
Journal:  HSS J       Date:  2013-06-21

5.  Efficacy of umbilical cord-derived mesenchymal stem cell-based therapy for osteonecrosis of the femoral head: A three-year follow-up study.

Authors:  Chun Chen; Zhiguo Qu; Xiaoguang Yin; Chunyu Shang; Qiang Ao; Yongquan Gu; Ying Liu
Journal:  Mol Med Rep       Date:  2016-09-16       Impact factor: 2.952

6.  Mid-term subsidence and periprosthetic radiolucency of the AMIStem: a 5-year EBRA-FCA analysis.

Authors:  Julian Hasler; Andreas Flury; Dimitris Dimitriou; Iris Holweg; Naeder Helmy; Michael Finsterwald
Journal:  J Orthop Surg Res       Date:  2021-01-07       Impact factor: 2.359

7.  Migration analysis of a metaphyseal anchored short-stem hip prosthesis.

Authors:  Florian Schmidutz; Thomas Graf; Farhad Mazoochian; Andreas Fottner; Andrea Bauer-Melnyk; Volkmar Jansson
Journal:  Acta Orthop       Date:  2012-08       Impact factor: 3.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.